6年多来,我院采用肝动脉插管化疗或栓塞治疗中晚期肝癌4000多人次,本文结合文献对以下几个问题进行了讨论:1、门脉主干癌栓和动门脉瘘是否TAE的禁忌症?如何处理?2、栓塞部位的分类;我们提出了远、中、近三段分类法;3、动脉内化疗、栓塞的方法;4、抗癌药物与栓塞剂的选配;5、并发症;6、不同治疗方法的疗效比较。 For more than 6 years, our hospital has used hepatic artery catheterization chemotherapy or embolization to treat more than 4,000 patients with advanced hepatocellular carcinoma. This article combined the literature to discuss the following questions: 1. Is portal vein cancer thrombosis and portal venous fistula TAE? Contraindications? How to deal with? 2. Classification of embolization sites; We propose a far, middle and near three-stage classification; 3. Intra-arterial chemotherapy and embolization methods; 4. Selection of anti-cancer drugs and embolic agents; Complications; 6. Comparison of efficacy of different treatment methods.